Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118427813 | 11842781 | 3 | F | 20140217 | 20160725 | 20151216 | 20160802 | EXP | JP-ASTRAZENECA-2015SF19872 | ASTRAZENECA | 62.00 | YR | M | Y | 0.00000 | 20160803 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118427813 | 11842781 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 702.5 | MG | 21366 | 2.5 | MG | TABLET | QD | |||||
| 118427813 | 11842781 | 2 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | 4 IU; NUMBER OF SEPARATE DOSAGES UNKNOWN | 0 | ||||||||||
| 118427813 | 11842781 | 3 | C | SUREPOST | REPAGLINIDE | 1 | Unknown | 1 MG; NUMBER OF SEPARATE DOSAGES UNKNOWN | 0 | ||||||||||
| 118427813 | 11842781 | 4 | C | SUREPOST | REPAGLINIDE | 1 | Unknown | 1 MG; NUMBER OF SEPARATE DOSAGES UNKNOWN | 0 | ||||||||||
| 118427813 | 11842781 | 5 | C | EQUA | VILDAGLIPTIN | 1 | Unknown | 100 MG; NUMBER OF SEPARATE DOSAGES UNKNOWN | 0 | ||||||||||
| 118427813 | 11842781 | 6 | C | TRAZENTA | LINAGLIPTIN | 1 | Unknown | 5 MG; NUMBER OF SEPARATE DOSAGES UNKNOWN | 0 | ||||||||||
| 118427813 | 11842781 | 7 | C | IMIDAPRIL HYDROCHLORIDE | IMIDAPRIL HYDROCHLORIDE | 1 | Unknown | 2.5 MG; NUMBER OF SEPARATE DOSAGES UNKNOWN | 0 | ||||||||||
| 118427813 | 11842781 | 8 | C | AZILVA | AZILSARTAN KAMEDOXOMIL | 1 | Unknown | 20 MG; NUMBER OF SEPARATE DOSAGES UNKNOWN | 0 | ||||||||||
| 118427813 | 11842781 | 9 | C | LANDEL 40 | 2 | Unknown | 40 MG EVERY DAY; NUMBER OF SEPARATE DOSAGES UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118427813 | 11842781 | 1 | Hypercholesterolaemia |
| 118427813 | 11842781 | 2 | Diabetes mellitus |
| 118427813 | 11842781 | 3 | Diabetes mellitus |
| 118427813 | 11842781 | 4 | Diabetes mellitus |
| 118427813 | 11842781 | 5 | Diabetes mellitus |
| 118427813 | 11842781 | 6 | Diabetes mellitus |
| 118427813 | 11842781 | 7 | Hypertension |
| 118427813 | 11842781 | 8 | Hypertension |
| 118427813 | 11842781 | 9 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118427813 | 11842781 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118427813 | 11842781 | Cardiac failure acute | |
| 118427813 | 11842781 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118427813 | 11842781 | 1 | 20130527 | 0 | ||
| 118427813 | 11842781 | 2 | 20130107 | 0 | ||
| 118427813 | 11842781 | 3 | 20130304 | 20131101 | 0 | |
| 118427813 | 11842781 | 4 | 20131125 | 20131224 | 0 | |
| 118427813 | 11842781 | 5 | 20130304 | 20130712 | 0 | |
| 118427813 | 11842781 | 6 | 20130713 | 0 | ||
| 118427813 | 11842781 | 7 | 20130415 | 20130712 | 0 | |
| 118427813 | 11842781 | 8 | 20130713 | 0 | ||
| 118427813 | 11842781 | 9 | 20131101 | 0 |